Chengjiao Zhang1, Guangfu Hu2, Ewelina Biskup3,4, Xiaochun Qiu5, Hongwei Zhang6, Haiyin Zhang7,8. 1. Department of Psychological Measurement, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2. Department of Breast Surgery, Shanghai Huangpu District Central Hospital, Shanghai, China. 3. Shanghai University of Medicine and Health Sciences, Shanghai, China. 4. Department of Internal Medicine, University Hospital of Basel, University of Basel, Basel, Switzerland. 5. Medical School Library, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 6. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.hongwei@zs-hospital.sh.cn. 7. Department of Psychological Measurement, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. haiyinz2001@126.com. 8. Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. haiyinz2001@126.com.
Abstract
BACKGROUND: To carry out a systematic review and meta-analysis of the literature to determine whether different type of surgery induces different depression occurrence in female breast cancer at mean time more than 1-year term postoperatively. METHODS: A systematic literature search of PubMed, Web of Science, EMBASE, OvidSP, EBSCO and PsycARTICLES was conducted. Observational clinical studies that compared the depression incidence in different surgery groups and presented empirical findings were selected. RESULTS: Sixteen studies met the inclusion criteria, including 5, 4, 2 and 5 studies compared depression between total mastectomy (TM) and breast conserving therapy (BCS), TM and breast reconstruction (BR), BCS and BR, or among all three groups (TM, BCS and BR), respectively. Only 1 of 5 studies, which subjected to multivariate analysis of depression in female breast cancer, reported a statistically significant effect of type of surgery on depression occurrence. Our meta-analysis showed no significant differences among the three types of surgery, with BCS patients versus TM patients (relative risk [RR] = 0.89, 95% confidence interval [CI] 0.78-1.01; P = 0.06), BR patients versus TM patients (RR = 0.87, 95% CI 0.71-1.06; P = 0.16) and BCS patients versus BR patients (RR = 1.10; 95% CI 0.89-1.35; P = 0.37), respectively. CONCLUSIONS: Our study showed that there were no statistically significant differences concerning the occurrence of depressive symptoms in breast cancer patients as a consequence of TM, BCS or BR at mean time more than 1-year term postoperatively.
BACKGROUND: To carry out a systematic review and meta-analysis of the literature to determine whether different type of surgery induces different depression occurrence in female breast cancer at mean time more than 1-year term postoperatively. METHODS: A systematic literature search of PubMed, Web of Science, EMBASE, OvidSP, EBSCO and PsycARTICLES was conducted. Observational clinical studies that compared the depression incidence in different surgery groups and presented empirical findings were selected. RESULTS: Sixteen studies met the inclusion criteria, including 5, 4, 2 and 5 studies compared depression between total mastectomy (TM) and breast conserving therapy (BCS), TM and breast reconstruction (BR), BCS and BR, or among all three groups (TM, BCS and BR), respectively. Only 1 of 5 studies, which subjected to multivariate analysis of depression in female breast cancer, reported a statistically significant effect of type of surgery on depression occurrence. Our meta-analysis showed no significant differences among the three types of surgery, with BCS patients versus TM patients (relative risk [RR] = 0.89, 95% confidence interval [CI] 0.78-1.01; P = 0.06), BR patients versus TM patients (RR = 0.87, 95% CI 0.71-1.06; P = 0.16) and BCS patients versus BR patients (RR = 1.10; 95% CI 0.89-1.35; P = 0.37), respectively. CONCLUSIONS: Our study showed that there were no statistically significant differences concerning the occurrence of depressive symptoms in breast cancerpatients as a consequence of TM, BCS or BR at mean time more than 1-year term postoperatively.
Authors: Wayne A Bardwell; Loki Natarajan; Joel E Dimsdale; Cheryl L Rock; Joanne E Mortimer; Kathy Hollenbach; John P Pierce Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: J Fernández-Delgado; M J López-Pedraza; J A Blasco; E Andradas-Aragones; J I Sánchez-Méndez; G Sordo-Miralles; M M Reza Journal: Ann Oncol Date: 2008-04-04 Impact factor: 32.976
Authors: Francesca Luzzati; Emanuele Maria Giusti; Gennaro Maria Scotto; Giuseppe Perrucchini; Luca Cannavò; Gianluca Castelnuovo; Andrea Colonna Cottini Journal: Support Care Cancer Date: 2019-07-01 Impact factor: 3.603
Authors: Elvin T Ng; Russell Z Ang; Bach X Tran; Cyrus S Ho; Zhisong Zhang; Wanqiu Tan; Yu Bai; Min Zhang; Wilson W Tam; Roger C Ho Journal: Int J Environ Res Public Health Date: 2019-12-06 Impact factor: 3.390